https://finviz.com/quote?t=PHIO&ta=1&p=d
PHIO - Phio Pharmaceuticals Corp Stock Price and Quote
PHIO - Phio Pharmaceuticals Corp - Stock screener for investors and traders, financial visualizations.
phio pharmaceuticalsstock pricecorpquote
https://phiopharma.com/
Home - Phio Pharmaceuticals
Dec 16, 2025 - Innovative Pathways Toward a Cancer-Free Future
phiopharmaceuticals
https://finviz.com/quote?t=PHIO&ta=1&p=d&ty=fc
PHIO - Phio Pharmaceuticals Corp Forecast, Target Price
PHIO - Phio Pharmaceuticals Corp - Stock screener for investors and traders, financial visualizations.
phio pharmaceuticalscorpforecasttargetprice
https://smartechchemistry.com/
Phio Pure & Nature Ingredients: The Best in Household Cleaning Products
Clean your home with the best household cleaning products from Smartech Chemistry. Our products are effective, affordable, and eco-friendly. Shop now
pure naturethe besthousehold cleaningphioingredients
https://www.home.saxo/cs-cz/markets/stocks/phio-xnas
Phio Pharmaceuticals Corp. akcie | Saxo Bank
Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed...
phio pharmaceuticalscorpakciesaxobank
https://www.prnewswire.com/news-releases/phio-pharmaceuticals-announces-research-collaboration-with-carisma-therapeutics-to-evaluate-its-self-delivering-rnai-technology-to-enhance-macrophage-based-adoptive-cell-therapy-300913536.html
Phio Pharmaceuticals Announces Research Collaboration with Carisma Therapeutics to Evaluate its...
/PRNewswire/ -- Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on...
phio pharmaceuticalsresearch collaborationannounces
https://www.newsfilecorp.com/release/292112/Phio-Pharmaceuticals-Announces-Nobel-Prize-Winning-Science-Takes-on-Skin-Cancer-in-a-Fireside-Chat-with-Force-Family-Office-on-Wednesday-April-15-2026
Phio Pharmaceuticals Announces "Nobel Prize Winning Science Takes on Skin Cancer" in a Fireside...
Phio invites investors, advisors and analysts with an interest in the life sciences sector to attend this virtual eventR....
https://finviz.com/news/308970/whats-going-on-with-tiny-cancer-biotech-phio-pharmaceuticals-on-thursday
What's Going On With Tiny Cancer Biotech Phio Pharmaceuticals On Thursday?
Stock screener for investors and traders, financial visualizations.
what s going onphio pharmaceuticals
https://www.newsfilecorp.com/release/273014/Phio-Pharmaceuticals-Announces-Exercise-of-Warrants-for-Approximately-13.4-Million-Gross-Proceeds
Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $13.4 Million Gross Proceeds
King of Prussia, Pennsylvania--(Newsfile Corp. - November 3, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage siRNA biopharmaceutical...
https://finviz.com/news/21651/phio-stock-soars-as-safety-panel-clears-skin-cancer-drug-for-next-dose
PHIO Stock Soars as Safety Panel Clears Skin Cancer Drug for Next Dose
Stock screener for investors and traders, financial visualizations.
https://www.newsfilecorp.com/release/286314
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual...
phio pharmaceuticalsin thefinancial communicationsannouncesparticipation
https://www.biospace.com/phio-pharmaceuticals-announces-closing-of-4-million-concurrent-registered-direct-offering-and-private-placement-priced-at-the-market-under-nasdaq-rules
Phio Pharmaceuticals Announces Closing of $4 Million Concurrent Registered Direct Offering and...
Jun 5, 2023 - Phio Pharmaceuticals Corp. announced the closing of its previously announced registered direct offering of 233,646 shares of common stock, at a purchase price...
phio pharmaceuticalsof 4
https://www.prnewswire.com/news-releases/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021-301365371.html
Phio Pharmaceuticals Announces Upcoming Data Presentation at the ESMO Virtual Congress 2021
/PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on...
phio pharmaceuticalsdata presentation
https://www.benzinga.com/quote/PHIO/short-interest
Phio Pharmaceuticals Stock Short Interest Report | NASDAQ:PHIO | Benzinga
Short interest for Phio Pharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of Phio Pharmaceuticals's stock....
phio pharmaceuticalsshort intereststockreportnasdaq
https://www.newsfilecorp.com/release/291688/Phio-Pharmaceuticals-Announces-Presentation-at-Centri-Capital-Conference-on-April-14-2026
Phio Pharmaceuticals Announces Presentation at Centri Capital Conference on April 14, 2026
King of Prussia, Pennsylvania--(Newsfile Corp. - April 9, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical...
centri capital conferencephio pharmaceuticals
https://www.financialcontent.com/quote/NQ:PHIO/about
The History Of Phio Pharmaceuticals Corp. - Common Stock (Nasdaq:PHIO) | FinancialContent
Phio Pharmaceuticals Corp., traded under the ticker PHIO on the Nasdaq exchange, is an example of a clinical-stage biotechnology company whose story weaves...
the history ofphio pharmaceuticalscommon stockcorpnasdaq
https://finviz.com/quote?t=PHIO&ta=1&p=d&ty=oc
PHIO - Phio Pharmaceuticals Corp Options
PHIO - Phio Pharmaceuticals Corp - Stock screener for investors and traders, financial visualizations.
phio pharmaceuticalscorpoptions
https://www.macrotrends.net/stocks/charts/PHIO/phio-pharmaceuticals/total-share-holder-equity
Phio Pharmaceuticals Share Holder Equity 2012-2025 | PHIO | MacroTrends
Phio Pharmaceuticals share holder equity from 2012 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
phio pharmaceuticalsshare holderequity20122025
https://www.biospace.com/press-releases/phio-pharmaceuticals-reports-second-quarter-2024-financial-results-and-provides-business-update
Phio Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update -...
2024 financial resultsphio pharmaceuticalssecond quarter
https://www.newsfilecorp.com/release/291688
Phio Pharmaceuticals Announces Presentation at Centri Capital Conference on April 14, 2026
King of Prussia, Pennsylvania--(Newsfile Corp. - April 9, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical...
centri capital conferencephio pharmaceuticals
https://www.joomlart.com/forums/t/ja-phio?page=2
JA Phio - Support Central
All discussions with the JA Phio tag
japhiosupportcentral
https://www.benzinga.com/quote/PHIO/analyst-ratings
Phio Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:PHIO | Benzinga
Explore Phio Pharmaceuticals analyst ratings and price targets (NASDAQ:PHIO) on Benzinga. Stay updated on expert opinions and forecasts for PHIO stock.
phio pharmaceuticalsanalyst ratingsprice targetsnasdaqbenzinga
https://shannoncooney.org/
Portfolio and creative showcase Joomla template - JA Phio - Shannon Cooney - Dancer, Choreographer,...
JA Phio is a versatile portfolio and creative showcase Joomla template to create slick, modern and fast portfolio, blog website without coding.
creative showcasejoomla template
https://www.newsfilecorp.com/release/256738/Phio-Pharmaceuticals-Announces-Positive-Safety-Monitoring-Committee-Recommendation-to-Advance-INTASYL-PH762-Skin-Cancer-Clinical-Trial-to-Fifth-Dose-Escalation-Cohort
Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance...
-Phio's lead clinical siRNA compound PH-762 demonstrates supportive safety profile in fourth cohort, permitting dose escalation in expected final...
phio pharmaceuticalssafety monitoringannouncespositivecommittee
https://www.home.saxo/nb-no/markets/stocks/phio-xnas
Phio Pharmaceuticals Corp. aksje | Saxo Bank
Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed...
phio pharmaceuticalscorpaksjesaxobank
https://www.newsfilecorp.com/release/225579/Phio-Announces-Data-Showcasing-INTASYLs-Role-in-Helping-Immune-Cells-Target-and-Kill-Cancer-Cells
Phio Announces Data Showcasing INTASYL's Role in Helping Immune Cells Target and Kill Cancer Cells
INTASYL compounds also improve the functionality and outcomes of adoptive cell therapies such as NK, TIL and CAR-TMarlborough, Massachusetts--(Newsfile Corp....
https://www.newsfilecorp.com/release/250330/Phio-Pharmaceuticals-Announces-Participation-in-the-Renmark-Financial-Communications-Virtual-NonDeal-Roadshow-Series
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual...
Marlborough, Massachusetts--(Newsfile Corp. - May 1, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company...
phio pharmaceuticalsin thefinancial communicationsannouncesparticipation
https://www.home.saxo/markets/stocks/phio-xnas
Phio Pharmaceuticals Corp. stock | Saxo
Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed...
phio pharmaceuticalscorpstocksaxo
https://www.biospace.com/phio-pharmaceuticals-announces-exercise-of-warrants-for-3-1-million-gross-proceeds
Phio Pharmaceuticals Announces Exercise of Warrants for $3.1 Million Gross Proceeds - BioSpace
https://www.phio-cells.com/
PHIO Cells
phiocells
https://phio-scientific.com/
PHIO scientific - Live Cell Monitoring
Mar 30, 2026 - Explore PHIO scientific, inside-Incubator Microscopes for Live-Cell Monitoring, designed to enhance your research.
phioscientificlivecellmonitoring
https://www.benzinga.com/quote/PHIO/news
Latest Phio Pharmaceuticals Stock News | NASDAQ:PHIO | Benzinga
Get the latest news on Phio Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on PHIO performance
phio pharmaceuticalsstock newslatestnasdaqbenzinga
https://www.newsfilecorp.com/company/10407/
Phio Pharmaceuticals Corp. | TMX Newsfile
Phio Pharmaceuticals Corp. at TMX Newsfile
phio pharmaceuticalscorptmxnewsfile